Meeting slides
Suggested Readings

Phenotypic characterization of eosinophilic esophagitis in a large multicenter patient population from the Consortium for Food Allergy Research.

Chehade M, et al. J Allergy Clin Immunol Pract. 2018;6(5):1534-1544.e5

Mechanisms of disease of eosinophilic esophagitis.

Davis BP, Rothenberg ME. Annu Rev Pathol. 2016;11:365-393.

A phase 3, randomized, 3-part study to investigate the efficacy and safety of dupilumab in adult and adolescent patients with eosinophilic esophagitis: results from part A.

Dellon ES. American College Gastroenterology Conference. October 26, 2020. Abstract LB3.

Budesonide oral suspension improves outcomes in patients with eosinophilic esophagitis: results from a phase 3 trial.

Hirano I, et al. Clin Gastroenterol Hepatol. 2021. doi: 10.1016/j.cgh.2021.04.022. [Epub ahead of print.]

Effects of race and sex on features of eosinophilic esophagitis.

Moawad FJ, et al. Clin Gastroenterol Hepatol. 2016;14(1):23-30.

Dietary therapy for eosinophilic esophagitis.

Molina-Infant J, Lucendo AJ. J Allergy Clin Immunol. 2018;142(1):41-47.

Eosinophilic esophagitis: a review.

Muir A, Falk GW. JAMA. 2021.326(13):1310-1318.

Pathophysiology of eosinophilic esophagitis.

O’Shea KM, et al. Gastroenterology. 2018;154(2):333-345

Medical algorithm: diagnosis and treatment of EoE in children.

Spergel JM, et al. Allergy. 2020;75(6):1522-1524.